334 related articles for article (PubMed ID: 19645665)
1. Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethylation.
Patra SK; Bettuzzi S
Biochemistry (Mosc); 2009 Jun; 74(6):613-9. PubMed ID: 19645665
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
3. 6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.
Wang H; Wang Y
Biochemistry; 2009 Mar; 48(10):2290-9. PubMed ID: 19236003
[TBL] [Abstract][Full Text] [Related]
4. The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.
Al-Salihi M; Yu M; Burnett DM; Alexander A; Samlowski WE; Fitzpatrick FA
Epigenetics; 2011 Aug; 6(8):1021-8. PubMed ID: 21725200
[TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Côté S; Sinnett D; Momparler RL
Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
[TBL] [Abstract][Full Text] [Related]
7. Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.
Miki K; Shimizu E; Yano S; Tani K; Sone S
Oncol Res; 2001; 12(8):335-42. PubMed ID: 11589304
[TBL] [Abstract][Full Text] [Related]
8. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dna methylation by 5-aza-2'-deoxycytidine correlates with induction of K562 cells differentiation.
Fabianowska-Majewska K; Wyczechowska D; Czyz M
Adv Exp Med Biol; 2000; 486():343-7. PubMed ID: 11783512
[No Abstract] [Full Text] [Related]
11. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
Hagemann S; Heil O; Lyko F; Brueckner B
PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.
Birdwell CE; Queen KJ; Kilgore PC; Rollyson P; Trutschl M; Cvek U; Scott RS
J Virol; 2014 Oct; 88(19):11442-58. PubMed ID: 25056883
[TBL] [Abstract][Full Text] [Related]
13. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
Gray SG; Baird AM; O'Kelly F; Nikolaidis G; Almgren M; Meunier A; Dockry E; Hollywood D; Ekström TJ; Perry AS; O'Byrne KJ
Int J Mol Med; 2012 Dec; 30(6):1505-11. PubMed ID: 23007409
[TBL] [Abstract][Full Text] [Related]
15. The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Zhuang J; Luan P; Li H; Wang K; Zhang P; Xu Y; Peng W
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):84-97. PubMed ID: 27879253
[TBL] [Abstract][Full Text] [Related]
16. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
Hsi LC; Xi X; Wu Y; Lippman SM
Mol Cancer Ther; 2005 Nov; 4(11):1740-6. PubMed ID: 16275995
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct.
Yu Z; Kong Q; Kone BC
Am J Physiol Renal Physiol; 2013 Oct; 305(7):F1006-13. PubMed ID: 23926181
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Control of the Vasopressin Promoter Explains Physiological Ability to Regulate Vasopressin Transcription in Dehydration and Salt Loading States in the Rat.
Greenwood MP; Greenwood M; Gillard BT; Loh SY; Paton JF; Murphy D
J Neuroendocrinol; 2016 Apr; 28(4):n/a. PubMed ID: 26833868
[TBL] [Abstract][Full Text] [Related]
19. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
Christman JK
Oncogene; 2002 Aug; 21(35):5483-95. PubMed ID: 12154409
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development.
Patra SK; Patra A; Rizzi F; Ghosh TC; Bettuzzi S
Cancer Metastasis Rev; 2008 Jun; 27(2):315-34. PubMed ID: 18246412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
